Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Møller Pedersen

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Oncology Reports|December 19, 2001
The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancerNils Milman, Lars Møller Pedersen
Leukemia & Lymphoma|May 27, 2004
Urinary albumin excretion is a predictor of response to treatment and disease progression in low-grade non-Hodgkin's lymphomaLars Møller Pedersen, Peter Grundtvig Sørensen
British Journal of Haematology|April 16, 2003
Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphomaLars Møller Pedersen, Peter Grundtvig Sørensen
Ugeskrift for Laeger|June 9, 2009
[Seizure triggered by benzodiazepine receptor antagonist]Lars Møller Pedersen, Morten Petersen, Inger Søndergaard
Ugeskrift for Laeger|August 11, 2021
[Impacted foetal head at emergency caesarean sections]Monica Lauridsen Kujabi, Lis Brooks, Lars Møller Pedersen, et al.
Advances in Hematology|August 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical TrialsSophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen, et al.
PET Clinics|June 9, 2015
Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell LymphomaKaren Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen, et al.
Annals of Hematology|April 19, 2005
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphomaLars Møller Pedersen, Tobias Wirenfeldt Klausen, Ulla Høy Davidsen, et al.
Ugeskrift for Laeger|August 12, 2022
[Clinical management of haematology in Greenland]Johan Skov Bundgaard, Alice Juhl Petersen, Uka W Geisler, et al.
Ejhaem|September 2, 2022
Inactivating <i>BTK</i> mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with <i>BCL2</i> translocationLone Schejbel, Marie Fredslund Breinholt, Anne Ortved Gang, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Oncology Reports|December 19, 2001
The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancerNils Milman, Lars Møller Pedersen
Leukemia & Lymphoma|May 27, 2004
Urinary albumin excretion is a predictor of response to treatment and disease progression in low-grade non-Hodgkin's lymphomaLars Møller Pedersen, Peter Grundtvig Sørensen
British Journal of Haematology|April 16, 2003
Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphomaLars Møller Pedersen, Peter Grundtvig Sørensen
Ugeskrift for Laeger|June 9, 2009
[Seizure triggered by benzodiazepine receptor antagonist]Lars Møller Pedersen, Morten Petersen, Inger Søndergaard
Ugeskrift for Laeger|August 11, 2021
[Impacted foetal head at emergency caesarean sections]Monica Lauridsen Kujabi, Lis Brooks, Lars Møller Pedersen, et al.
Advances in Hematology|August 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical TrialsSophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen, et al.
PET Clinics|June 9, 2015
Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell LymphomaKaren Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen, et al.
Annals of Hematology|April 19, 2005
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphomaLars Møller Pedersen, Tobias Wirenfeldt Klausen, Ulla Høy Davidsen, et al.
Ugeskrift for Laeger|August 12, 2022
[Clinical management of haematology in Greenland]Johan Skov Bundgaard, Alice Juhl Petersen, Uka W Geisler, et al.
Ejhaem|September 2, 2022
Inactivating <i>BTK</i> mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with <i>BCL2</i> translocationLone Schejbel, Marie Fredslund Breinholt, Anne Ortved Gang, et al.
Pageof 5